GATA1 and Schnyder corneal dystrophy: ,24,25,26,27 It has been recently proposed to use the base editing technology to disrupt the GATA1 activator BS in the erythroid-specific BCL11A enhancer without creating InDels, and reactivate HbF in the progeny of SCD and β-thalassemia patient HSPCs.16